A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy
There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to...
Gespeichert in:
Veröffentlicht in: | Heart and vessels 2020-08, Vol.35 (8), p.1164-1170 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1170 |
---|---|
container_issue | 8 |
container_start_page | 1164 |
container_title | Heart and vessels |
container_volume | 35 |
creator | Kageyama, Shigetaka Mitake, Hirotsugu Nakajima, Atsuo Kodama, Keita Hattori, Yusuke Watanabe, Yuzo Sugiyama, Hirofumi Kawahito, Michitomo Takeuchi, Ryosuke Murata, Koichiro Nawada, Ryuzo Onodera, Tomoya |
description | There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or > 2 of the following factors: SBP 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery. |
doi_str_mv | 10.1007/s00380-020-01583-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2378897893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2419738766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</originalsourceid><addsrcrecordid>eNp9kUFvFCEUx4mxsdvqF_BgSLx4GQu8nQGOm0atSRMv7ZmwzKNLnRlGYNrs9_ADy3arJh48EAj_H3_ee39C3nL2kTMmLzJjoFjDRF28VdDAC7LiHW8b0Up4SVZMc9YoEPKUnOV8zyqluX5FTkFw1a51uyI_N3SKDzjQFPJ3ml1MSONEbT-GnEM9-ZjonLAProTpjvZoy47WuwmxfxLzku4w7WmY6GxLwKlk-hgqZN1SkJb9jHRT1ZLsuCQ70B2OtsTR0oQOw8PBdTz4V6nsMNl5_5qceDtkfPO8n5Pbz59uLq-a629fvl5urhsHWpemdbBWwDRzkquthF6KjgEyj4Cyh61F2Xrtte6c5t3a-144r5hGraEVrYBz8uHoO6f4Y8FcTO3a4TDYCeOSjQCplJZKQ0Xf_4PexyVNtToj1lxLULLrKiWOlEsx54TezCmMNu0NZ-aQmTlmZmpm5ikzc7B-92y9bOsg_jz5HVIF4AjkKk112H___o_tL_BFo0M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419738766</pqid></control><display><type>article</type><title>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Kageyama, Shigetaka ; Mitake, Hirotsugu ; Nakajima, Atsuo ; Kodama, Keita ; Hattori, Yusuke ; Watanabe, Yuzo ; Sugiyama, Hirofumi ; Kawahito, Michitomo ; Takeuchi, Ryosuke ; Murata, Koichiro ; Nawada, Ryuzo ; Onodera, Tomoya</creator><creatorcontrib>Kageyama, Shigetaka ; Mitake, Hirotsugu ; Nakajima, Atsuo ; Kodama, Keita ; Hattori, Yusuke ; Watanabe, Yuzo ; Sugiyama, Hirofumi ; Kawahito, Michitomo ; Takeuchi, Ryosuke ; Murata, Koichiro ; Nawada, Ryuzo ; Onodera, Tomoya</creatorcontrib><description>There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or > 2 of the following factors: SBP < 120 mmHg, ascending aorta diameter > 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.</description><identifier>ISSN: 0910-8327</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-020-01583-3</identifier><identifier>PMID: 32185495</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Aged ; Aged, 80 and over ; Aorta ; Aortic Diseases - diagnostic imaging ; Aortic Diseases - mortality ; Aortic Diseases - therapy ; Aortic dissection ; Biomedical Engineering and Bioengineering ; Blood pressure ; Cardiac Surgery ; Cardiology ; Clinical Decision Rules ; Clinical Decision-Making ; Computed tomography ; Conservative Treatment - adverse effects ; Conservative Treatment - mortality ; Coronary vessels ; Death ; Effusion ; Emergency Service, Hospital ; Female ; Forecasting ; Health services ; Hematoma ; Hematoma - diagnostic imaging ; Hematoma - mortality ; Hematoma - therapy ; Humans ; Japan ; Male ; Medical treatment ; Medicine ; Medicine & Public Health ; Middle Aged ; Mortality ; Multivariate analysis ; Original Article ; Patient Admission ; Patients ; Predictive Value of Tests ; Retrospective Studies ; Risk analysis ; Risk Assessment ; Risk Factors ; Risk groups ; Sensitivity analysis ; Surgery ; Treatment Outcome ; Vascular Surgery ; Vascular Surgical Procedures - adverse effects ; Vascular Surgical Procedures - mortality</subject><ispartof>Heart and vessels, 2020-08, Vol.35 (8), p.1164-1170</ispartof><rights>Springer Japan KK, part of Springer Nature 2020</rights><rights>Springer Japan KK, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</citedby><cites>FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00380-020-01583-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00380-020-01583-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32185495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kageyama, Shigetaka</creatorcontrib><creatorcontrib>Mitake, Hirotsugu</creatorcontrib><creatorcontrib>Nakajima, Atsuo</creatorcontrib><creatorcontrib>Kodama, Keita</creatorcontrib><creatorcontrib>Hattori, Yusuke</creatorcontrib><creatorcontrib>Watanabe, Yuzo</creatorcontrib><creatorcontrib>Sugiyama, Hirofumi</creatorcontrib><creatorcontrib>Kawahito, Michitomo</creatorcontrib><creatorcontrib>Takeuchi, Ryosuke</creatorcontrib><creatorcontrib>Murata, Koichiro</creatorcontrib><creatorcontrib>Nawada, Ryuzo</creatorcontrib><creatorcontrib>Onodera, Tomoya</creatorcontrib><title>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><addtitle>Heart Vessels</addtitle><description>There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or > 2 of the following factors: SBP < 120 mmHg, ascending aorta diameter > 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aorta</subject><subject>Aortic Diseases - diagnostic imaging</subject><subject>Aortic Diseases - mortality</subject><subject>Aortic Diseases - therapy</subject><subject>Aortic dissection</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Blood pressure</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Clinical Decision Rules</subject><subject>Clinical Decision-Making</subject><subject>Computed tomography</subject><subject>Conservative Treatment - adverse effects</subject><subject>Conservative Treatment - mortality</subject><subject>Coronary vessels</subject><subject>Death</subject><subject>Effusion</subject><subject>Emergency Service, Hospital</subject><subject>Female</subject><subject>Forecasting</subject><subject>Health services</subject><subject>Hematoma</subject><subject>Hematoma - diagnostic imaging</subject><subject>Hematoma - mortality</subject><subject>Hematoma - therapy</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Original Article</subject><subject>Patient Admission</subject><subject>Patients</subject><subject>Predictive Value of Tests</subject><subject>Retrospective Studies</subject><subject>Risk analysis</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Risk groups</subject><subject>Sensitivity analysis</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><subject>Vascular Surgery</subject><subject>Vascular Surgical Procedures - adverse effects</subject><subject>Vascular Surgical Procedures - mortality</subject><issn>0910-8327</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFvFCEUx4mxsdvqF_BgSLx4GQu8nQGOm0atSRMv7ZmwzKNLnRlGYNrs9_ADy3arJh48EAj_H3_ee39C3nL2kTMmLzJjoFjDRF28VdDAC7LiHW8b0Up4SVZMc9YoEPKUnOV8zyqluX5FTkFw1a51uyI_N3SKDzjQFPJ3ml1MSONEbT-GnEM9-ZjonLAProTpjvZoy47WuwmxfxLzku4w7WmY6GxLwKlk-hgqZN1SkJb9jHRT1ZLsuCQ70B2OtsTR0oQOw8PBdTz4V6nsMNl5_5qceDtkfPO8n5Pbz59uLq-a629fvl5urhsHWpemdbBWwDRzkquthF6KjgEyj4Cyh61F2Xrtte6c5t3a-144r5hGraEVrYBz8uHoO6f4Y8FcTO3a4TDYCeOSjQCplJZKQ0Xf_4PexyVNtToj1lxLULLrKiWOlEsx54TezCmMNu0NZ-aQmTlmZmpm5ikzc7B-92y9bOsg_jz5HVIF4AjkKk112H___o_tL_BFo0M</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Kageyama, Shigetaka</creator><creator>Mitake, Hirotsugu</creator><creator>Nakajima, Atsuo</creator><creator>Kodama, Keita</creator><creator>Hattori, Yusuke</creator><creator>Watanabe, Yuzo</creator><creator>Sugiyama, Hirofumi</creator><creator>Kawahito, Michitomo</creator><creator>Takeuchi, Ryosuke</creator><creator>Murata, Koichiro</creator><creator>Nawada, Ryuzo</creator><creator>Onodera, Tomoya</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20200801</creationdate><title>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</title><author>Kageyama, Shigetaka ; Mitake, Hirotsugu ; Nakajima, Atsuo ; Kodama, Keita ; Hattori, Yusuke ; Watanabe, Yuzo ; Sugiyama, Hirofumi ; Kawahito, Michitomo ; Takeuchi, Ryosuke ; Murata, Koichiro ; Nawada, Ryuzo ; Onodera, Tomoya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-5c3483090c718b73d72603e0fe3e7d3bae75f9f996c9164ffd2cf809e99352523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aorta</topic><topic>Aortic Diseases - diagnostic imaging</topic><topic>Aortic Diseases - mortality</topic><topic>Aortic Diseases - therapy</topic><topic>Aortic dissection</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Blood pressure</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Clinical Decision Rules</topic><topic>Clinical Decision-Making</topic><topic>Computed tomography</topic><topic>Conservative Treatment - adverse effects</topic><topic>Conservative Treatment - mortality</topic><topic>Coronary vessels</topic><topic>Death</topic><topic>Effusion</topic><topic>Emergency Service, Hospital</topic><topic>Female</topic><topic>Forecasting</topic><topic>Health services</topic><topic>Hematoma</topic><topic>Hematoma - diagnostic imaging</topic><topic>Hematoma - mortality</topic><topic>Hematoma - therapy</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Original Article</topic><topic>Patient Admission</topic><topic>Patients</topic><topic>Predictive Value of Tests</topic><topic>Retrospective Studies</topic><topic>Risk analysis</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Risk groups</topic><topic>Sensitivity analysis</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><topic>Vascular Surgery</topic><topic>Vascular Surgical Procedures - adverse effects</topic><topic>Vascular Surgical Procedures - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kageyama, Shigetaka</creatorcontrib><creatorcontrib>Mitake, Hirotsugu</creatorcontrib><creatorcontrib>Nakajima, Atsuo</creatorcontrib><creatorcontrib>Kodama, Keita</creatorcontrib><creatorcontrib>Hattori, Yusuke</creatorcontrib><creatorcontrib>Watanabe, Yuzo</creatorcontrib><creatorcontrib>Sugiyama, Hirofumi</creatorcontrib><creatorcontrib>Kawahito, Michitomo</creatorcontrib><creatorcontrib>Takeuchi, Ryosuke</creatorcontrib><creatorcontrib>Murata, Koichiro</creatorcontrib><creatorcontrib>Nawada, Ryuzo</creatorcontrib><creatorcontrib>Onodera, Tomoya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kageyama, Shigetaka</au><au>Mitake, Hirotsugu</au><au>Nakajima, Atsuo</au><au>Kodama, Keita</au><au>Hattori, Yusuke</au><au>Watanabe, Yuzo</au><au>Sugiyama, Hirofumi</au><au>Kawahito, Michitomo</au><au>Takeuchi, Ryosuke</au><au>Murata, Koichiro</au><au>Nawada, Ryuzo</au><au>Onodera, Tomoya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy</atitle><jtitle>Heart and vessels</jtitle><stitle>Heart Vessels</stitle><addtitle>Heart Vessels</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>35</volume><issue>8</issue><spage>1164</spage><epage>1170</epage><pages>1164-1170</pages><issn>0910-8327</issn><eissn>1615-2573</eissn><abstract>There has been continuing discussion regarding the treatment strategy for acute type A intramural hematoma (IMH). Most patients are treated conservatively in Japan; hence, predicting fatal events and stratifying risks based on results normally obtained on hospital arrival are important. We aimed to examine the incidences and risk factors of death or need for surgery for acute type A IMH in patients receiving medical treatment and to identify high-risk patients using clinical findings on hospital arrival. From 2011 to 2016, 57 consecutive patients (mean age 72.5 years; male 36.8%) diagnosed with acute type A IMH who were receiving treatment at Shizuoka City Shizuoka Hospital were retrospectively included. Primary endpoint was a composite of cardiovascular death and operation within 1 year after onset. To evaluate sensitivity and specificity of the risk factors and risk score, we estimated the area under the receiver operating characteristic (ROC) curve. Mean follow-up duration was 621 days. Mean systolic blood pressure (SBP) was 129 mmHg. Computed tomography (CT) on arrival showed a mean ascending aorta diameter of 46 mm. Ulcer-like projection (ULP) in the ascending aorta and pericardial effusion (PE) were seen in 33% and 42% of cases, respectively. Twenty-eight patients (49.1%) reached the primary endpoint (cardiovascular death, 7 cases [12.3%]; operation, 21 cases [36.8%]). In univariate analysis of admission values, the primary endpoint group had significantly lower SBP (113.0 ± 28.5 vs 144.3 ± 33.5 mmHg), higher ascending aorta diameter (49.5 ± 8.1 vs 43.6 ± 5.9 mm), and higher frequency of ULP (53.8% vs 13.8%) and PE (58.6% vs 25.0%) than the event-free group. Multivariate analysis showed that ULP on admission CT was a significant predictor of the primary endpoint. The risk score was considered using these risk factors. On admission, the primary endpoint could be predicted with 89.7% sensitivity and 75% specificity (area under the ROC curve 0.823) if the patient had ULP and/or > 2 of the following factors: SBP < 120 mmHg, ascending aorta diameter > 45 mm, and PE. SBP and CT findings on arrival were significantly associated with cardiovascular death and the need for surgery in patients with acute type A IMH receiving initial medical therapy. The novel risk score was useful for predicting cardiovascular death and surgery.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>32185495</pmid><doi>10.1007/s00380-020-01583-3</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0910-8327 |
ispartof | Heart and vessels, 2020-08, Vol.35 (8), p.1164-1170 |
issn | 0910-8327 1615-2573 |
language | eng |
recordid | cdi_proquest_miscellaneous_2378897893 |
source | MEDLINE; SpringerNature Journals |
subjects | Aged Aged, 80 and over Aorta Aortic Diseases - diagnostic imaging Aortic Diseases - mortality Aortic Diseases - therapy Aortic dissection Biomedical Engineering and Bioengineering Blood pressure Cardiac Surgery Cardiology Clinical Decision Rules Clinical Decision-Making Computed tomography Conservative Treatment - adverse effects Conservative Treatment - mortality Coronary vessels Death Effusion Emergency Service, Hospital Female Forecasting Health services Hematoma Hematoma - diagnostic imaging Hematoma - mortality Hematoma - therapy Humans Japan Male Medical treatment Medicine Medicine & Public Health Middle Aged Mortality Multivariate analysis Original Article Patient Admission Patients Predictive Value of Tests Retrospective Studies Risk analysis Risk Assessment Risk Factors Risk groups Sensitivity analysis Surgery Treatment Outcome Vascular Surgery Vascular Surgical Procedures - adverse effects Vascular Surgical Procedures - mortality |
title | A novel risk score on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A07%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20risk%20score%20on%20admission%20for%20predicting%20death%20or%20need%20for%20surgery%20in%20patients%20with%20acute%20type%20A%20intramural%20hematoma%20receiving%20medical%20therapy&rft.jtitle=Heart%20and%20vessels&rft.au=Kageyama,%20Shigetaka&rft.date=2020-08-01&rft.volume=35&rft.issue=8&rft.spage=1164&rft.epage=1170&rft.pages=1164-1170&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-020-01583-3&rft_dat=%3Cproquest_cross%3E2419738766%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419738766&rft_id=info:pmid/32185495&rfr_iscdi=true |